© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Substance Name: Sertaconazole Nitrate
Chemical Formula: C20H15Cl3N2O4S·HNO3
Common Uses: Used in topical antifungal treatments for skin infections, Sertaconazole nitrate manages common issues like athlete’s foot, ringworm, and jock itch by inhibiting fungal cell membrane synthesis. Its relevance in over-the-counter and prescription medications helps ease discomfort and brings relief to people battling fungal skin issues.
Appearance: White or almost white, crystalline powder
Odor: Odorless
Recommended Therapeutic Application: External use on skin affected by fungal growth, avoids systemic use due to low systemic absorption after topical administration.
Classification: Not universally classified as hazardous under GHS, but exposure to fine powders may cause mild irritation to skin, eyes, and respiratory tract. Prolonged or repeated contact with the compound, as with many active pharmaceutical raw materials, brings the risk of sensitization particularly for those involved in production work.
Primary Routes of Exposure: Inhalation of dust, skin contact, accidental eye contact.
Pictograms: None required for consumer formulation, but workplace settings may still use the exclamation mark to indicate minor irritation hazards.
Symptoms of Overexposure: Itchy or reddened skin, sneezing or coughing from dust, stinging sensation if it contacts mucous membranes.
Precautionary Statements: Keep dust down in workspace, avoid direct skin contact, ensure workspaces have good ventilation to reduce airborne particles.
Main Active Component: Sertaconazole nitrate, concentration depends on formulation purpose.
Impurities: Trace synthesis byproducts and residual solvents possible in production material; finished pharmaceutical products must comply with pharmacopeial standards limiting impurities.
Chemical Class: Imidazole antifungal
CAS Number: 99592-32-2 (for Sertaconazole nitrate)
Inhalation: Move person to fresh air; allow person to breathe freely; seek medical attention if cough or other symptoms persist.
Skin Contact: Rinse affected skin with lukewarm water and mild soap; remove contaminated clothing and wash before reuse; consult doctor for persistent irritation.
Eye Contact: Rinse with plenty of clean, lukewarm water, keep eyelid open for several minutes to ensure thorough flushing; consider professional medical assessment for persistent discomfort or vision changes.
Ingestion: Seek prompt medical advice. While systemic toxicity from incidental ingestion is unlikely, proper evaluation is essential, especially in children or sensitive individuals.
Suitable Extinguishing Media: Water spray, carbon dioxide, dry chemical, or foam; standard firefighting gear for chemical fires suffices.
Fire Hazards: Compound does not present a significant flammability risk in storage or normal use. During combustion, it can release irritating or toxic vapors including nitrogen oxides, sulfur oxides, and hydrogen chloride.
Special Protective Equipment: Standard protective equipment; avoid inhaling fumes; contain runoff.
Personal Precautions: Wear protective gloves and safety goggles; minimize dust formation and inhalation by dampening spilled powder.
Cleanup Procedures: Sweep gently into secure, labeled container for disposal; ventilate area to minimize inhalation hazard; avoid creation of airborne dust.
Environmental Protection: Avoid direct release into drains or water systems; environmental toxicity for aquatic organisms appears low at therapeutic concentrations, but responsible disposal remains a regulatory focus.
Handling: Use in ventilated area; avoid creation of dust and direct skin or eye contact; implement training for workers in pharma manufacturing or compounding settings; enforce proper use of PPE.
Storage Conditions: Store at controlled room temperature, away from moisture and direct sunlight; keep container tightly closed; segregate from incompatible chemicals like strong oxidizers. In healthcare and pharmacy settings, restricting access prevents accidental misuse and preserves potency.
Engineering Controls: Use local exhaust ventilation in workrooms handling pharmaceutical powders; maintain negative pressure in production areas to prevent dust migration.
Personal Protection: Wear lightweight gloves, lab coats, and safety glasses when handling raw compound; consider dust masks or respirators in bulk manufacturing or compounding spaces; provide eye wash stations and handwashing sinks.
Occupational Exposure Limits: No official OEL in most jurisdictions, but prudent control of airborne particles protects against respiratory irritation and minimizes risk of employee sensitization.
Physical State: Solid, crystalline
Color: White to off-white
pH: Slightly acidic in aqueous suspension
Solubility: Sparingly soluble in water, increased solubility in various organic solvents
Odor: Odorless
Melting Point: Approximately 159°C–163°C (decomposition)
Molecular Weight: Approximately 493.8 g/mol (for nitrate salt)
Chemical Stability: Stable under recommended storage conditions, but exposure to moisture or light may degrade compound.
Incompatible Materials: Strong oxidizing agents, strong acids and bases.
Hazardous Decomposition Products: Combustion or thermal breakdown produces nitrogen oxides, sulfur oxides, and hydrogen chloride whose inhalation carries health risks.
Conditions to Avoid: Prolonged exposure to high humidity and excessive heat reduces shelf life and effectiveness.
Acute Toxicity: Low systemic toxicity from topical use due to minimal absorption. Studies in animals show high LD50; rarely causes significant health problems at doses encountered in skin products.
Irritation: Mild to moderate irritation is possible with direct skin, eye, or respiratory exposure in manufacturing or compounding facilities. In real-world pharmaceutical use, hypersensitivity reactions are rare but possible.
Chronic Effects: No evidence for carcinogenicity or mutagenicity in reported studies; repeated skin contact with raw powder might cause occupational sensitization in a small subset of workers.
Sensitization: Documented risk of allergic dermatitis from chronic exposure to active ingredient in workplace or through therapeutic use; safety protocols help protect manufacturing employees.
Environmental Fate: Compound degrades slowly in the environment; breakdown occurs via microbial activity and photolysis.
Aquatic Toxicity: Not acutely toxic to aquatic organisms at levels expected from pharmaceutical use; large accidental releases ought to be contained to prevent unnecessary environmental persistence.
Bioaccumulation: No significant bioaccumulation predicted; structurally this compound does not show high lipid solubility.
Persistence: As with many pharmaceuticals, persistence in landfill or water bodies can occur, making proper treatment of waste streams from pharmaceutical manufacturing a worthwhile effort.
Waste Treatment Methods: Collect unused or spilled raw material for disposal via approved incineration or hazardous waste treatment; avoid contamination of municipal water supplies.
Disposal of Pharmaceutically Finished Products: Direct medicine take-back programs where available; household medicine should not go down the drain; community education can reduce improper disposal.
Legal Compliance: Adhere to local and national regulations on pharmaceutical waste, which reduces unnecessary release of active ingredients into the environment and protects sanitation workers from exposure.
UN Number: Not classified as dangerous for transportation according to major laws; products containing sertaconazole nitrate move freely as standard consumer goods.
Transportation Hazards: Small risk of irritation or accidental inhalation for handlers of bulk powder drum shipments; package securely in robust, sealed, labeled containers.
Special Precautions: Maintain containers upright, sealed, and protected from excessive heat or moisture; medical supply chains monitor storage conditions to preserve product quality.
Status: Sertaconazole nitrate appears on several national lists for registration of active pharmaceutical ingredients.
Worker Safety Laws: Occupational health authorities encourage risk assessment for pharmaceutical manufacturing tasks including personal protection and dust reduction, especially for workers with known chemical sensitivities.
Environmental Regulations: Persistent monitoring required in industrial settings, as regulations increasingly target the effects of pharmaceutical compounds in wastewater.
Prescription Status: Finished medicines containing sertaconazole nitrate require a prescription in some jurisdictions; regulatory authorities require ongoing reporting of adverse events to monitor for unexpected toxicity.
